Revvity, Inc. (Revvity) provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure.
Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics, and more. The company markets its products and services in more than 160 countries.
Strate...
Revvity, Inc. (Revvity) provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure.
Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics, and more. The company markets its products and services in more than 160 countries.
Strategy
The company’s strategy is to develop and deliver innovative products, services, and solutions in high-growth markets that utilize its knowledge and expertise to address customers’ critical needs and drive scientific breakthroughs. To execute on the company’s strategy and accelerate revenue growth, it focuses on broadening its offerings through both investment in research and development, and the acquisition of innovative technology.
The company’s strategy includes strengthening its position within key markets by expanding its global product and service offerings, maintaining superior product quality, and driving an enhanced customer experience; accelerating transformational innovation through both internal research and development, and third-party collaborations and alliances; and augmenting growth in both of its core business segments, Life Sciences and Diagnostics, through strategic acquisitions and licensing.
Business Segments and Products
The company operates through two segments, Life Sciences and Diagnostics.
Life Sciences segment
The company’s comprehensive portfolio of technologies helps life sciences researchers better understand diseases and develop treatments. It provides a broad suite of products, solutions, and services that facilitate optimized workflows, increase productivity, and accelerate every stage of the drug discovery and development pipeline. The company’s offerings span the areas of cell, gene, and protein research, enabling scientists to work smarter, make research breakthroughs, and transform those breakthroughs into real-world outcomes. The company partners with global pharmaceutical, biotech, and contract research organizations, as well as academic and government institutions, to enable them to discover and develop better treatments and therapeutics to fight disease faster and more efficiently.
Principal Products
The company’s principal products and services for Life Sciences applications include the following:
Reagents: Radiometric detection solutions, including over 750 radiochemicals and instrumentation such as the Tri-Carb and Quantulus GCT families of liquid scintillation analyzers, Wizard2 Gamma counters, and MicroBeta2 plate-based LSA, are used for beta, gamma, and luminescence counting in microplate and vial formats utilized in research, environmental, and drug discovery applications.
Reagents and solutions for microscopy and imaging applications. These include PhenoVue cellular imaging reagents and cell painting kits, PhenoPlate (formerly CellCarrier Ultra) cellular imaging microplates, and GrowDex hydrogels, fluorophore-conjugated and enzyme-conjugated antibodies, as well as buffers and solutions, such as its Ce3D collection of buffers for 3D tissue imaging.
A wide range of homogeneous biochemical and cell-based reagents using HTRF, LANCE Ultra, DELFIA, AlphaLISA, AlphaLISA SureFire Ultra, AlphaScreen, AlphaPlex, and luminescence assay technologies that can be paired with its microplates, which cover a variety of applications.
New assay kits for Adeno-associated Virus Vectors (AAVs) and gene therapy applications in the company’s range of HTRF and AlphaLISA reagents, for detecting and quantifying CHO HCP impurities in biotherapeutics development, as well as kits across oncology, neuroscience, and targeted protein degradation applications.
A broad portfolio of recombinant GPCR and ion channel cell lines, including over 300 products and 120 ready-to-use frozen cell lines for a wide range of disease areas.
Dharmacon reagents and gene modulation technologies such as RNAi that support drug discovery and development for greater understanding of gene function, identifying genetic drivers behind human disease, developing and validating diagnostic workflows, and helping deliver biotherapeutics, cellular, and gene therapies for precision medicine with a portfolio of cell engineering tools.
BioLegend ELISA MAX Standard Sets, ELISA MAX Deluxe Sets, LEGEND MAX ELISA Kits, and RAPID MAX ELISA Kits, as well as complementary solutions and buffers for immunoassays to cover more than 200 targets for human, mouse, and rat samples, many of which are designed to assess the immune environment and its inflammatory state for vaccine, infectious disease, and autoimmune disease research.
BioLegend LEGENDplex bead-based reagents, which, in contrast to single analyte assays such as enzyme-linked immunosorbent assays (ELISAs), can quantitate up to 14 targets from one small sample volume and read on common flow cytometers, and include both desktop and cloud-based analysis software.
BioLegend best-in-class antibodies, recombinant proteins, and related reagents are used across multiple applications and research areas, including proteogenomics, tissue, cell and protein analysis, cancer research, immunology, cell and gene therapy, stem cell therapy, and neuroscience.
Fluorophore-conjugated antibodies are used in flow cytometers to characterize protein expression on the surface and in internal compartments of cells. The large collection of dyes and antibodies allows for an increasing number of conjugate options, facilitating the use of bigger and better flow cytometry panels using conventional and spectral flow cytometers. Notable products are Brilliant Violet and the Spark and Fire dye series, among others.
BioLegend TotalSeq reagents are oligonucleotide-barcoded antibodies that enable protein detection to be combined with traditional RNA or DNA sequencing experiments with high-parameter protein detection.
Cell culture and biofunctional assay reagents, including bioactive recombinant proteins, as well as other specialized reagents, such as Cell-Vive T-NK Xeno-Free Serum Substitute (compliant with Good Manufacturing Practice requirements (GMP)), and other GMP-produced recombinant proteins and reagents. These products serve several markets, notably cell and gene therapy applications.
BioLegend’s MojoSort for cell separation that complements the company’s fluorophore-antibody conjugates, used for FACS (Fluorescence-activated Cell Sorting), thus covering most cell separation and cell sorting technologies and applications.
BioLegend’s catalog of more than 33,000 SKUs, incorporating antibodies and a large collection of antibody conjugates and modifications, as well as recombinant proteins, immunoassays, and other supportive reagents and solutions for cell and molecular analysis.
Flex-T reagents that utilize peptide-loaded major histocompatibility molecules assembled into tetramers for the identification of antigen-specific T cells. The company’s Flex-T products can be used to screen the efficacy of antigen peptides for vaccine and drug trials, as well as characterize the dominance of cancer-specific self-peptides, and more recently, SARS-CoV-2 peptides for COVID-19 research.
Antibodies and solutions for Western blotting, as well as supporting buffers and substrates, provide a convenient set of tools to characterize protein size and relative expression levels in cell or tissue lysates.
Mimix reference standards are cell line-derived to mimic patient samples and suitable for next-generation sequencing, droplet-digital, and real-time PCR as well as Sanger sequencing. The platform is agnostic for seamless integration into quality control workflows.
OptiScint NPE-free scintillation cocktails and quench standards, providing a more environmentally friendly alternative without compromising performance.
Expansion of the company’s Western blotting reagents with the addition of the Western Lightning One range, which has a pre-mixed one-component chemiluminescent HRP substrate for more consistent results.
Additional Spark and Fire dye-conjugated antibodies, enabling higher-parameter flow cytometry. Notable products are the Spark PLUS UV395 and Spark PLUS B550 conjugates.
For the TotalSeq reagent portfolio, more large panels of pre-titrated oligo-conjugated antibodies released in universal panels for the analysis of human and mouse samples. New options were created for intracellular target staining and protein-only analysis.
New fluorescent stains, reagents, and secondary antibodies in the company’s PhenoVue cellular imaging reagents portfolio for the detection and analysis of cellular components.
GoInVivo, as well as Ultra-LEAF and LEAF functional antibodies, provide an affordable solution for researchers performing in vivo and ex vivo studies.
Instruments
The Opera Phenix Plus high-content screening system for sensitive and high-speed phenotypic drug screening of complex cellular models.
The Operetta CLS high-content analysis system enables scientists to reveal fine sub-cellular details from everyday assays as well as more complex studies, for example using live cells, 3D, and stem cells.
The VICTOR Nivo multimode plate reader benchtop system designed for assay development and academic labs, including those using HTRF and AlphaLISA assay technologies.
The EnVision multimode plate reader designed for high-throughput screening laboratories, including those using HTRF, AlphaScreen, and AlphaLISA assay technologies.
The EnVision Nexus multimode plate reader, the company’s next-generation system for high-throughput screening with advanced detection technologies for Alpha, TRF, and Luminescence.
In vivo optical imaging platforms and reagents for preclinical research, consisting of the IVIS Spectrum series for 2D and 3D optical imaging and optionally integrated low-dose CT imaging, and the IVIS Lumina series for benchtop 2D imaging, along with IVISbrite bioluminescent and IVISense fluorescent imaging agents and imaging reagents.
The Quantum GX3 system, which enables low-dose in vivo CT imaging of multiple species and areas of anatomical interest across multiple disease areas by way of high-resolution, tomographic imaging.
The Vega ultrasound system, a hands-free automated ultrasound platform that delivers high-resolution 2D and 3D imaging in just a few minutes. This innovative in vivo ultrasound system removes the challenges associated with conventional hand-held systems through the use of automated transducers located under the imaging stage and is easy to use, requires minimal training, and produces more consistent results. It is complemented by GoInVivo, as well as Ultra-LEAF and LEAF functional antibodies, providing an affordable solution for researchers performing in vivo and ex vivo studies.
The high-throughput, microwell Celigo image cytometry system, the Cellaca MX high-throughput cell counter, the Cellaca PLX image cytometry system, and the Cellometer automated cell counters, complemented by consumables and reagents, including reagents and kits for cell counting assays and cell viability, microplates, slides, and counting beads.
The Cellaca PLX image cytometry system combines best-in-class image cytometer hardware, software, validated consumables, and optimized reagent kits with validated antibodies from the company’s BioLegend business, and trackable data reporting to enable the simultaneous detection of multiple markers and to streamline cell and gene therapy workflows.
Software
The Signals Image Artist next-generation image analysis and management platform for drug discovery research, to help scientists process and analyze high-content screening (HCS) and cellular imaging data in a matter of hours versus days or weeks.
The Signals Research platform equips pharmaceutical scientists with essential tools to gather, search, mine, analyze, and visualize critical data, yielding actionable insights in an automated, predictive, and scalable manner. Within life science research and development, and clinical research applications, the company’s software accelerates innovation, development, collaboration, and research, ultimately leading to accelerated life-enhancing medical breakthroughs, promoting its vision of a healthier humankind. Additionally, it empowers scientists and formulators in specialty chemical and food sciences to analyze food and additives, and create high-performing materials that align with sustainability initiatives, promoting energy efficiency, lower toxicity, and a circular economy.
The Signals Notebook secure cloud-native electronic lab notebook (ELN) for chemistry, biology, research, and formulations. From increased collaboration to securely accessible data, the Signals Notebook offering accelerates research and development workflows, increases collaboration, integrates with Microsoft Office, and more.
Signals ChemDraw software provides solutions with powerful capabilities and integrations to help quickly turn ideas and drawings into publications since 1985. Signals ChemDraw software automates chemical drawings and transforms them into chemical knowledge by facilitating the management, reporting, and presenting of chemistry research.
Signals Clinical offering provides a single unified platform to support data access, preparation, and analytics, from source to visualization to action. With unrivaled workflow flexibility to support dynamic collaboration, Signals Clinical’s SaaS solution helps accelerate the delivery of urgently needed therapeutics to patients.
Signals DLX powered by Scitara establishes seamless, bidirectional connectivity across instruments, LIMS, ELNs, and other critical lab systems that previously existed in isolation.
The latest version of the Signals Image Artist next-generation image analysis and management platform provides improved 3D cell segmentation and analysis, an AWS S3 cloud deployment option, enhanced cloud security, and compatibility with a broader range of systems, including the Nexcelom from Revvity Celigo image cytometer.
An updated VICTOR Nivo multimode plate reader with a new software version for streamlined data analysis.
Software solutions for BioLegend LEGENDplex assays and multiomics analysis with TotalSeq reagents, that are now part of BioLegend’s data integration offerings.
Technology and Licensing
The Pin-point base editing platform is a CRISPR-Cas9-based technology that allows researchers to make precision base changes in genomic DNA. Editing with such precision can be used to silence disease-causing genes, correct disease-associated mutations, and optimize cell therapies.
The CHOSOURCE platform was expanded to include a CHO-K1 ADCC+ expression cell line for the development of therapeutic antibodies in oncology, infectious disease, and autoimmune conditions.
Gene Delivery services and technologies to design and manufacture viral vectors for cell and gene therapy research and preclinical development. This includes LentiBOOST transduction enhancer technology for improved lentiviral transduction efficiency, helping to reduce the cost of goods for cell therapies.
Preclinical services for oncology leverage capabilities, such as cell panel screening, cell line engineering, functional genomic screening, and immune cell screening, for a range of applications to help accelerate the drug development process.
New Products
New products introduced or acquired for Life Sciences applications in fiscal year 2024 include the following:
Reagents: BioLegend launched new dyes to expand flow cytometry panel building options, including PE/Fire 744, Spark PLUS UV395, Spark PLUS B550 antibody conjugates, and Zombie UV387 for dead cell analysis. In addition, the Flexi-Fluor portfolio of reagents was created as a made-to-order, rapid alternative to traditional custom products.
Oligo-conjugated antibodies for intracellular detection of proteins and cytokines introduced in BioLegend's TotalSeq portfolio. BioLegend also introduced a solution for high-throughput, high-parameter single-cell protein analysis - TotalSeq PhenoCyte. PhenoCyte provides a streamlined, instrument-free workflow for scalable single-cell immunoprofiling.
Instruments
The Cellometer Ascend automated cell counter accelerates lab workflow by mitigating human error, all while providing a consistent, standardized cell count. Incorporated with its user-friendly Matrix software, this product performs an automated and sophisticated image analysis workflow that delivers reliable results in seconds.
Software
Phenologic.AI software, a module in the company’s Harmony high-content imaging and analysis software, and in its Signals Image Artist image analysis and data management platform, uses a pre-trained deep-learning image-analysis model to enable analysis of brightfield images and provides an additional channel for multiplexing and easier analysis of live cell assays.
Brand Names
The company’s Life Sciences segment offers additional products under various brand names:
Accell, AdenoBOOST, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, BioLegend, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, Chem3D, ChemDraw, ChemOffice, CHOSOURCE, DELFIA, Dharmacon, DharmaFECT, Edit-R, ELISA MAX, EnVision, EnVision Nexus, Flex-T, FMT, FolateRSense, GoInVivo, HTRF, ImmuSignature, IVIS, IVISbrite, IVISense, LANCE, LANCE Ultra, LEAF, LEGEND MAX, LEGENDplex, LentiBOOST, Lincode, Living Image, Lumina, MicroBeta, Mimix, Mini ELISA Plate Reader, miRIDIAN, MojoSort, MuviCyte, NEN, OncoSignature, OncoSpan, ON-TARGET, ON-TARGETplus, Opera Phenix Plus, Operetta-CLS, OptiScint, PhenoPlate, PhenoVue, Pin-point, Quantulus GCT, Quantum, RAPID MAX, RediJect, RNAiONE, Signals, Signals Image Artist, SMARTpools, SMARTvector, Spark PLUS, Spectrum, TotalSeq, Tri-Carb, Ultra-LEAF, Vega, VesselVue, ViaStain, VICTOR Nivo, Western Lightning, and Wizard2.
Diagnostics segment
The company offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company’s Diagnostics segment is especially focused on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics.
The company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. The company’s screening products are designed to provide early and accurate insights into the health of expectant mothers during pregnancy and into the health of their babies. Diagnostic labs use the company’s instruments, reagents, and software for testing and screening genetic abnormalities and certain disorders and diseases, including Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using PCR and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery.
Principal Products
The company’s principal products and services for Diagnostics applications include the following:
Reproductive Health
The DELFIA Xpress screening platform, a complete solution for prenatal and maternal health screening including a fast continuous loading system. It is supported by kits for first, second, and third trimester analyses for prenatal screening and clinically validated LifeCycle software.
The DELFIA Xpress sFlt-1 kit enables short-term prediction of pre-eclampsia and aids in diagnosis in the second and third trimesters of pregnancy together with the previously launched DELFIA Xpress PlGF 1-2-3 assay.
The NeoBase non-derivatized MS/MS AAAC kits are used to support detection of metabolic disorders in newborns through tandem mass spectrometry. The kits analyze newborn dry blood spot samples for measurement of amino acids and other metabolic analytes for specific diseases.
The GSP Neonatal hTSH, T4 17á-OHP, GALT IRT, BTD, PKU, Total Galactose, CK-MM, and G6PD kits are used for screening congenital neonatal conditions from a drop of blood.
The Specimen Gate informatics data management solution is designed specifically for newborn screening laboratories.
The NeoLSD MS/MS kit is the first commercial IVD kit for screening of Pompe, MPS-I, Fabry, Gaucher, Niemann-Pick A/B, and Krabbe disorders from a single dried blood spot sample.
QSight 210MD and 225MD UHPLC MS/MS instruments are used for newborn screening.
Vanadis NIPT is a non-PCR, non-sequencing fully automated cfDNA technology for use in any laboratory for screening common trisomies in the pregnant population.
The EONIS assay, a CE-marked and the United States Food and Drug Administration (FDA) authorized system, utilizes real-time PCR technology, which allows for simultaneous screening of SMA, SCID, and XLA in newborns from a single DBS punch.
EONIS Q is a novel dry-chemistry qPCR newborn screening workflow for SCID, SMA, and XALD screening.
The DELFIA Trio automated plate dispenser, washer, and disk remover are used for the manual newborn screening and prenatal workflows.
EVOYA is a cloud-based, newborn screening, informatics, and data management software.
ViaCord offers umbilical cord blood banking services for the banking of stem cells harvested from umbilical cord blood and cord tissue, for potential therapeutic application in transplant and regenerative medicine.
Revvity Omics is a global laboratory network offering multi-OMIC clinical-grade services for testing over an individual’s lifetime (prenatal to adults) in cytogenetics, biochemical genetics, molecular genetics, and immunodiagnostics. The laboratory network includes testing laboratories in the United States, Sweden, India, China, and the United Kingdom.
Utilizing next-generation sequencing, Revvity Omics labs provide testing solutions including, but not limited to, whole genome sequencing, whole exome sequencing, curated, and customized gene panels.
Revvity Omics Whole Genome Sequencing test provides dual genome analysis (nuclear and mitochondrial) detecting single nucleotide variants, chromosomal and intragenic copy number events, short tandem repeats analysis for more than 30 genes, and SMN1 copy number characterization. This test also provides additional findings like pharmacogenomic analysis and carrier status, among others.
The Ultrarapid Whole Genome Sequencing test, a variant of the whole genome sequencing (WGS) analysis, bundles the StepOne biochemical profile, cCMV analysis, and metagenomic analysis with the standard WGS analysis to help babies in the NICU with a result as fast as five days.
Using WGS as a backbone, Revvity Omics provides two unique products, the CNGnome NGS Array and WholePanel test. Utilizing uniform coverage across the genome, the CNGnome NGS array is used to detect copy number events over 25kb in size, making this a new gold standard in CNV detection. The WholePanel test provides enhanced coverage including the intronic regions for the expertly curated WholeCancer, WholeAtaxia, WholeCardiology, and WholeMuscularDystrophy gene panels.
Applied Genomics
The Omni Bead Ruptor Elite Bead Mill Homogenizer enables grinding, lysing, and homogenization of biological samples prior to molecular analyte extraction, delivering repeatable sample disassociation.
The Omni Prep 96 Automated Homogenizer Workstation is a fully automated homogenizer enabling true walk-away processing for high-throughput labs.
Automated liquid handling platforms (Fontus, JANUS, Sciclone, Zephyr, and FlexDrop) offer a choice of robotic solutions in genomics, biotherapeutics, high throughput screening, and high content analysis to assist life science research from bench to clinic.
JANUS BioTx and PreNAT II workstations provide automated small-scale purification, offering column, tip, and plate-based chromatography on a single platform.
The LabChip GXII Touch protein characterization system provides a means of characterizing multiple protein product attributes for research labs through QC.
The explorer automated workstation allows integration of multiple laboratory instrumentation using a centralized robotic interface, allowing high throughput and turnkey-application focused solutions.
The PG-Seq Rapid kit v2 analyzes picogram quantities of DNA from an embryo biopsy for preimplantation genetic research with enhanced whole genome coverage and accuracy.
The DOPlify WGA V2 kit performs fast whole genome amplification on single cells or limited template DNA samples, allowing cell chromosome copy number status to be determined.
NEXTFLEX library prep kits simplify library prep with optimized protocols and reagents, making the library preparation process more efficient and reliable.
Automation protocols and kits launched for the BioQule NGS System make it an open system that combines automation, reagents, consumables, and scripts, enabling walkaway automation to simplify low throughput nucleic acid isolation, NGS library preparation, and quantitation.
The Fontus liquid handler is available in multiple versions to automate both NGS and life science workflows.
Immunodiagnostics
The chemagic Prime instrument is a fully automated, LIMS-compatible solution for primary sample transfer, DNA and RNA isolation, normalization, and the setup of PCR and Next Generation Sequencing (NGS) applications.
The chemagic 360 instrument is a flexible solution for automated nucleic acid isolation from 0.1-18 ml sample volumes of diverse sample materials. The chemagic 360-D instrument (IVDR) and chemagic Prime Junior-D instrument (IVDR), together with the chemagic IVD Kits, are the optimal choice for automated IVDR-compliant nucleic acid isolation for clinical diagnostics.
The Oxford Immunotec T-SPOT Technology platform is a modified ELISPOT used to detect a T cell immune response to infection.
The Oxford Immunotec T-SPOTTB test is an in vitro diagnostic test for the detection of effector T cells that respond to stimulation by mycobacterium tuberculosis antigens by capturing interferon gamma in the vicinity of T cells in human whole blood. It is intended for use as an aid in the diagnosis of tuberculosis infection.
An expanded portfolio of molecular-based infectious disease screening technologies for blood bank and clinical laboratory settings in China includes a qualitative 3-in-1 assay for the detection of hepatitis B, hepatitis C, and HIV, as well as assays for other communicable diseases.
TRF-based Anti HBs/HCV/TP kits are used for infectious disease testing.
The Chitas instrument and HBV/HCV/HIV 3-in-1 PCR reagents are utilized for blood screening, and Hi Sensitivity HBV DNA and HCV RNA assays are employed for clinical infectious disease testing.
Chemiluminescence immunoassays and ELISA are available for therapeutic drug monitoring.
A comprehensive portfolio of chemiluminescence immunoassays and ELISAs is provided for endocrinology testing.
Radioactive immunoassays are utilized in testing calcium metabolism.
Autoimmune testing includes indirect immunofluorescence tests (IIFT), ELISA, chemiluminescence immunoassays, and immunoblots, covering rheumatology, hepatology, gastroenterology, endocrinology, neurology, nephrology, dermatology, and infertility.
Allergy testing covers allergen-specific immunoglobulin E (IgE), measuring the level of different IgE antibodies or total IgE in blood using multiplex EUROLINE immunoblot assays, as well as singleplex chemiluminescence immunoassays.
Infectious disease testing includes IIFT, ELISA, chemiluminescence immunoassays, immunoblots, microarrays, and real-time PCR, covering bacteria, viruses, fungi, and parasites.
A complete portfolio of chemiluminescence immunoassays (ChLIA) is available for precise Alzheimer’s disease diagnostics, providing reliable analysis of the established CSF biomarkers beta-amyloid (1-40), beta-amyloid (1-42), total tau, and pTau (181), with a high degree of standardization due to fully automated processing.
The EUROLabPolaris platform provides the secure transfer of indirect immunofluorescence data to several locations, enabling central evaluation within the software.
The EUROLabOffice4.0 laboratory management system provides a central interface between devices to simplify and speed up the diagnostic routine and increases security through the organization of all lab procedures and traceable documentation of all data and processes.
The EUROPattern Classifier 2.4 AI-enhanced software module of EUROLabOffice4.0 offers automated result proposals from images captured with the all-in-one IFA instrument UNIQO 160, as well as from the automated microscopes EUROPattern and EUROPattern Microscope Live.
The EUROLabWorkstation IFA and EUROLabWorkstation ELISA provide fully automated processing of IIFT and ELISA, respectively, for laboratories with high sample throughput.
The EUROPattern microscope provides fully automated immunofluorescence microscopy, including IIFT pattern recognition and titer determination.
The EUROPattern microscope live provides fully automated and fast image recording and modern on-screen reporting, also including IIFT pattern recognition and titer determination.
The EUROBlotOne is a compact tabletop device for complete processing of immunoblots.
The UNIQO160 device allows for fully automated processing of IIFT from primary sample to final microscopy result for up to 160 samples and 18 slides.
The IDS-i10 is a compact random-access solution for the processing of ChLIA in the field of autoimmune and infection diagnostics, as well as antigen detection, providing sample throughput of up to 170 tests per hour.
The IDS-iSYS Multi-Discipline Automated System is a compact automation solution for the processing of ChLIA in the field of autoimmune, infection, and allergy diagnostics, as well as antigen detection, providing sample throughput of up to 120 samples per hour.
MyFoodProfile immunoblots are used for the determination of IgG and IgE reactivity against more than 200 foods (CE-marked).
New Products
New products or services introduced or acquired for Diagnostics applications in fiscal year 2024 include the following:
Reproductive Health
CD34+ hematopoietic stem cells from human umbilical cord blood (for research use only and not for use in diagnostic procedures).
The NEXTFLEX Neo NGS RUO Panel 1 kit, which is part of a new end-to-end workflow solution for newborn sequencing research.
Revvity Genomics LIMS cloud-based genomic platform solution is primed for secure data management and LIS integration.
Revvity Genomics Analyze genomics primary and secondary analysis software for variant calling.
Revvity Genomics Interpret tertiary and reporting software for genomic testing.
Revvity Transcribe AI is an innovative OCR service designed to convert handwritten text on test request forms into a digitized format.
Applied Genomics
The LabChip Plasmid DNA assay enables purity and sizing analysis of the three primary isoforms of pDNA during the manufacturing of proteins, viral vectors, and messenger RNA.
Immunodiagnostics
The Auto-Pure 2400 automated liquid handling platform is designed to provide efficient workflows in the lab for T-SPOT.TB testing.
The EUROStar IV Plus is a new model of EUROIMMUN's successful LED microscope series for convenient manual fluorescence microscopy with attractive new features for easy and ergonomic manual microscopy.
The optimized (IVDR-compliant) RVTY CSF ELISA 2.0 series facilitates handling and resource savings.
The GeneProof-ALPCO portfolio for molecular diagnostics.
EURORealTime APOE for APOE genotyping to assess a patient’s risk for side effects prior to the start of anti-amyloid (beta) therapy in Alzheimer’s disease.
Brand Names:
The company’s Diagnostics segment offers additional products under various brand names, including:
AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BioQule, BoBs, chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Omni Bead Ruptor, Omni Bead Ruptor Elite, Omni Tip, Pannoramic, Panthera Puncher, PG-Seq, PG-Find, PreNAT II, Prime, Protein Clear, ProteinEXact, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord, VICTOR2D, and Zephyr.
Marketing
All of the company’s businesses market their products and services primarily through their own specialized sales forces. As of December 29, 2024, the company operated in approximately 40 countries and marketing products and services in more than 160 countries. In geographic regions where it does not have a sales and service presence, it utilizes distributors to sell its products.
Regulatory Affairs
The company’s operations are subject to regulation by different state and federal government agencies in the United States and other countries, as well as to the standards established by international standards bodies. Some of the company’s products are subject to regulation by the FDA and similar foreign agencies.
Research and Development
The company’s research and development expenses for fiscal year 2024 were $196.8 million.
History
The company, a Massachusetts corporation, was founded in 1937. It was incorporated in 1947. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in 2023.
